Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody
eLife · 2025
DOI: 10.7554/elife.100066 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Joar Esteban Pinto Torres und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Cellular and Molecular Immunology (CMIM), Vrije Universiteit Brussel (VUB), Brussel, Belgium. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Pyruvate Kinase, Trypanosoma brucei brucei. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vrije Universiteit Brussel, Universiteit Gent, Universiteit Antwerpen.
Abstract (Originalsprache)
African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Cellular and Molecular Immunology (CMIM), Vrije Universiteit Brussel (VUB), Brussel, Belgium.
- Laboratory of Microbiology, Parasitology and Hygiene (LMPH) and the Infla-Med Centre of Excellence, University of Antwerp, Wilrijk, Belgium.
- School of Biological Sciences, The University of Edinburgh, Edinburgh, United Kingdom.
- Laboratory of Medical Biochemistry (LMB) and the Infla-Med Centre of Excellence, University of Antwerp, Wilrijk, Belgium.
- Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
- Laboratory of Medicinal Chemistry, University of Antwerp, Wilrijk, Belgium.
ORCID-Profile: Wim Versées, Guy Caljon, Yann G-J Sterckx
Förderung
- Vrije Universiteit Brussel
- Universiteit Gent
- Universiteit Antwerpen
- Fonds Wetenschappelijk Onderzoek
- COST Action CA21111
Zitieren
APA
Pinto Torres, J. E., Claes, M., Hendrickx, R., Yuan, M., Smiejkowska, N., Van Wielendaele, P., Hacisuleyman, A., De Winter, H., Muyldermans, S., Michels, P. A. M., Walkinshaw, M. D., Versées, W., Caljon, G., Magez, S., & Sterckx, Y. G. (2025). Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody. eLife. https://doi.org/10.7554/elife.100066
Vancouver
Pinto Torres JE, Claes M, Hendrickx R, Yuan M, Smiejkowska N, Van Wielendaele P, et al. Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody. eLife. 2025. doi:10.7554/elife.100066
BibTeX
@article{PintoTorres2025,
author = {Pinto Torres, Joar Esteban and Claes, Mathieu and Hendrickx, Rik and Yuan, Meng and Smiejkowska, Natalia and Van Wielendaele, Pieter and Hacisuleyman, Aysima and De Winter, Hans and Muyldermans, Serge and Michels, Paul A M and Walkinshaw, Malcolm D and Versées, Wim and Caljon, Guy and Magez, Stefan and Sterckx, Yann G-J},
title = {Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.100066}
}
EUVIMED